BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38737681)

  • 1. Potential role of lncRNA LOXL1-AS1 in human cancer development: a narrative review.
    Tang M; Rong Y; Liu S; Wu Z; Ma G; Li X; Cai H
    Transl Cancer Res; 2024 Apr; 13(4):1997-2011. PubMed ID: 38737681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.
    Fu XP; Ji CY; Tang WQ; Yu TT; Luo L
    Clin Exp Med; 2024 May; 24(1):93. PubMed ID: 38693424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes.
    Do AD; Wu KS; Chu SS; Giang LH; Lin YL; Chang CC; Wong TT; Hsieh CL; Sung SY
    J Exp Clin Cancer Res; 2024 Apr; 43(1):130. PubMed ID: 38689348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
    Wu C; Zhang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma.
    Feng Z; Ye Z; Xie J; Chen W; Li W; Xing C
    Biol Direct; 2021 Dec; 16(1):24. PubMed ID: 34863279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA LOXL1-AS1 acts as a ceRNA for miR-324-3p to contribute to cholangiocarcinoma progression via modulation of ATP-binding cassette transporter A1.
    Zhang B; Zhou M; Zou L; Miao J; Wang Y; Li Y; Lu S; Yu J
    Biochem Biophys Res Commun; 2019 Jun; 513(4):827-833. PubMed ID: 31003776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA LOXL1-AS1 promotes liver cancer cell proliferation and migration by regulating the miR-377-3p/NFIB axis.
    Yu W; Dai Y
    Oncol Lett; 2021 Aug; 22(2):624. PubMed ID: 34267816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA LOXL1-AS1 promotes esophageal squamous cell carcinoma progression by targeting DESC1.
    Li H; Chu J; Jia J; Sheng J; Zhao X; Xing Y; He F
    J Cancer; 2021; 12(2):530-538. PubMed ID: 33391449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LOXL1-AS1 promotes proliferation and invasion and inhibits apoptosis in retinoblastoma by regulating the MAPK signaling pathway.
    Wu W; Zhang Y; Xu C; Yang H; Liu S; Huang G
    Mol Cell Biochem; 2024 Apr; 479(4):1011-1022. PubMed ID: 37273040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA LOXL1-AS1 is transcriptionally activated by JUND and contributes to osteoarthritis progression via targeting the miR-423-5p/KDM5C axis.
    Chen K; Fang H; Xu N
    Life Sci; 2020 Oct; 258():118095. PubMed ID: 32679142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA LOXL1-AS1 expression in cancer prognosis: A meta-analysis.
    Wang X; Chen Z; Zhou H; Liu W; Luo J
    Medicine (Baltimore); 2022 Dec; 101(52):e32436. PubMed ID: 36596047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
    Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
    Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis.
    Xue F; Xu YH; Shen CC; Qin ZL; Zhou HB
    Biomed Pharmacother; 2020 May; 125():109568. PubMed ID: 32058209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-coding RNA LOXL1-AS1 Facilitates Colorectal Cancer Progression via Regulating miR-1224-5p/miR-761/HK2 Axis.
    Guo T; Peng S; Liu D; Li Y
    Biochem Genet; 2022 Dec; 60(6):2416-2433. PubMed ID: 35441953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
    Chen S; Li W; Guo A
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysyl oxidase-like 1-antisense 1 (LOXL1-AS1) lncRNA differentially regulates gene and protein expression, signaling and morphology of human ocular cells.
    Schmitt HM; Hake KM; Perkumas KM; Lê BM; Suarez MF; De Ieso ML; Rahman RS; Johnson WM; Gomez-Caraballo M; Ashley-Koch AE; Hauser MA; Stamer WD
    Hum Mol Genet; 2023 Oct; 32(21):3053-3062. PubMed ID: 37540217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-Coding RNA LOXL1-AS1 Enhances Colorectal Cancer Proliferation, Migration and Invasion Through miR-708-5p/CD44-EGFR Axis.
    Wu X; Cui F; Chen Y; Zhu Y; Liu F
    Onco Targets Ther; 2020; 13():7615-7627. PubMed ID: 32821123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
    Yang X; Xing G; Liu S; Li B; He Y; Wang F
    Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.